After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.
Our experts can talk with you about whether a clinical trial is right for you. Clinical trials are research studies to test promising new treatments, procedures, or devices. Some even look at ways to ...
Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...
Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.
Addex spin-out Neurosterix begins phase 1 study with M4 PAM - NTX-253 for schizophrenia: Geneva, Switzerland Thursday, January 8, 2026, 12:00 Hrs [IST] Addex Therapeutics, a clini ...
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...
The numbers related to opioid dependence and addiction are staggering: More than 10 million people misuse opioids and almost 50,000 people die from opioid overdose every year -- a 519% increase since ...
WWLP Springfield on MSN
Governor Healey calls on RFK Jr. to restore clinical trial funding
Following his historic cuts to National Institutes of Health funding, R.F.K. Jr. told Governor Healey to prove that funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback